Statin-treated familial hypercholesterolemia patients with coronary heart disease and pronounced atherosclerosis do not have more brain lesions than healthy controls in later middle age

Acta Radiologica

Volumn 48, Issue 8, 2007, Pages 894-899

  Soljanlahti, S ^a,b   Raininko, R ^c   Hyttinen, L ^c   Lauerma, K ^c   Keto, P ^c   Vuorio, A F ^c   Autti, T ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Helsinki Medical Imaging Center ^*

Author keywords

Atherosclerosis; Brain; Familial hypercholesterolemia; Magnetic resonance imaging; Ultrasonography; White matter hyperintensity

Indexed keywords

BIOLOGICAL ORGANS; DISEASE CONTROL; HEALTH RISKS; MAGNETIC RESONANCE IMAGING; PATIENT TREATMENT; ULTRASONOGRAPHY;

ATHEROSCLEROSIS; FAMILIAL HYPERCHOLESTEROLEMIA; SILENT BRAIN LESIONS; WHITE MATTER HYPERINTENSITY;

DISEASES;

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ARTERY; BRAIN VEIN; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; ECHOGRAPHY; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RISK FACTOR;

AGED; ATHEROSCLEROSIS; CAROTID ARTERIES; CAROTID STENOSIS; CEREBRAL ARTERIES; CEREBRAL VEINS; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK FACTORS;

EID: 35148900679     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850701468891     Document Type: Article

References (29)

1. Autti T, Raininko R, Vanhanen SL, Kallio M, Santavuori P. MRI of the normal brain from early childhood to middle age. I. Appearances on T2- and proton density-weighted images and occurrence of incidental high-signal foci. Neuroradiology 1994;36:644-8.
2. Bansal BC, Sood AK, Bansal CB. Familial hyperlipidemia in stroke in the young. Stroke 1986;17:1142-5.
3. Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246-52.
4. D'Armiento FP, Bianchi A, de Nigris F, Capuzzi DM, D'Armiento M, Crimi G, et al. Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factor for atherosclerosis. Stroke 2001;32:2472-80.
5. DeCarli C, Massaro J, Harvey D, Hald J, Tullberg M, Au R, et al. Measures of brain morphology and infarction in the Framingham heart study: establishing what is normal. Neurobiol Aging 2005;26:491-510.
6. de Groot E, Hovingh GK, Wiegman A, Duriez P, Smit AJ, Fruchart J-C, et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 2004;109:33-8.
7. Frikke-Schmidt R, Arlien-Soborg P, Thorsen S, Jensen HK, Vorstrup S. LDL receptor mutations and ApoB mutations are not risk factors for ischemic cerebrovascular disease of the young, but lipids and lipoproteins are. Eur J Neurol 1999;6:691-6.
8. Gerdes VE, Kwa VI, Ten Cate H, Brandjes DP, Buller HR, Stam J. Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease. Atherosclerosis 2006;186:166-72.
9. Giele JL, Witkamp TD, Mali WP, van der Graaf Y, SMART Study Group. Silent brain infarcts in patients with manifest vascular disease. Stroke 2004;35:742-6.
10. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: grayscale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology 2003;229:340-6.
11. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, editors. The metabolic and molecular bases of inherited diseases. 8th ed. New York: McGraw-Hill Book Co.; 2001, p. 2863-913.
12. Hoeg JM, Feuerstein IM, Tucker EE. Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia. Arterioscler Thromb 1994;14:1066-74.
13. Huxley RR, Hawkins MH, Humphries SE, Karpe F, Neil HA, Simon Broome Familial Hyperlipidaemia Register GroupScientific Steering Committee. Risk of fatal stroke in patients with treated familial hypercholesterolemia: a prospective registry study. Stroke 2003;34:22-7.
14. Kaste M, Koivistoi P. Risk of brain infarction in familial hypercholesterolemia. Stroke 1988;19:1097-100.
15. Koivisto U-M, Turtola H, Aalto-Setälä K, Top B, Frants RR, Kovanen PT, et al. The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland. J Clin Invest 1992;90:219-28.
16. Koivisto U-M, Hamalainen L, Taskinen M-R, Kettunen K, Kontula K. Prevalence of familial hypercholesterolemia among young north Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction. J Lipid Res 1993;34:269-77.
17. Kuller LH, Longstreth WT Jr, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ Jr, Cardiovascular Health Study Collaborative Research Group. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 2004;35:1821-5.
18. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and metaanalysis. Br Med J 2003;326:1423.
19. Mabuchi H, Miyamoto S, Ueda K, Oota M, Takegoshi T, Wakasugi T, et al. Causes of death in patients with familial hypercholesterolemia. Atherosclerosis 1986;61:1-6.
20. Manolio TA, Burke GL, O'Leary DH, Evans G, Beauchamp N, Knepper L, et al. Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the Cardiovascular Health Study. Arterioscler Thromb Vase Biol 1999;19:356-65.
21. Pantoni L. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 2002;13:7-10.
22. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652-9.
23. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimai plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-406.
24. Salonen O, Autti T, Raininko R, Ylikoski A, Erkinjuntti T. MRI of the brain in neurologically healthy middle-aged and elderly individuals. Neuroradiology 1997;39:537-45.
25. Soljanlahti S, Autti T, Lauerma K, Raininko R, Keto P, Turtola H, et al. Familial hypercholesterolemia patients treated with statins at no increased risk for intracranial vascular lesions despite increased cholesterol burden and extracranial atherosclerosis. Stroke 2005;36:1572-4.
26. Uehara T, Tabuchi M, Hayashi T, Kurogane H, Yamadori A. Asymptomatic occlusive lesions of carotid and intracranial arteries in Japanese patients with ischemic heart disease: evaluation by brain magnetic resonance angiography. Stroke 1996;27:393-7.
27. Vaughan CJ, Delanty N, Basson CT. Statin therapy and stroke prevention. Curr Opin Cardiol 2001;16:219-24.
28. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003;34:1126-9.
29. Vuorio AF, Turtola H, Piilahti KM, Repo P, Kanninen T, Kontula K, Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study. Arterioscler Thromb Vase Biol 1997;17:3127-38.